FindTrial
Sign In

Impact of COVID-19 Pandemic on Acute Pancreatitis Presentations, Management and In-Hospital Outcomes: a Single-Center, Retrospective Observational Study from the Northeast of China

Acute Pancreatitis During COVID-19 Pandemic

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043350
Enrollment
Unknown
Registered
2021-02-11
Start date
2021-02-10
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

case series:Nil

Sponsors

Harbin Medical University Affiliated First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 91 Years

Inclusion criteria

Inclusion criteria: This retrospective study included all consecutive patients with both serological and imaging confirmed AP admitted to our hospital from January 23, 2020 (the first reported case of COVID-19 in Harbin and a nationwide first-level public health emergency response activated) to June 10, 2020 (the public health emergency response was downgraded to the third level in Harbin), which defined as the COVID-19 era group, compared with the same period in 2019.

Exclusion criteria

Exclusion criteria: Among individuals with multiple readmissions, only readmissions during the study period were included in the analysis.Patients visited for chronic.

Design outcomes

Primary

MeasureTime frame
ICU admission rate;—

Countries

China

Contacts

Public ContactXuewei Bai

Harbin Medical University Affiliated First Hospital

13213570623@163.com+86 13936439346

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026